Samantha Bobba
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Samantha Bobba has a total of 40 co-authors. Here are the top co-authors by number of shared publications:
- Stephanie Louise Watson
Save Sight Institute, Faculty of Medicine and Health, The University of Sydney, Sydney, Australia
4 shared publications Nick Di Girolamo
School of Medical Sciences, University of New South Wales, Kensington, Sydney, New South Wales, 2052, Australia
3 shared publications- Damien Gerard Harkin
Queensland University of Technology
2 shared publications Elsie Chan
Royal Victorian Eye and Ear Hospital, Centre for Eye Research Australia, University of Melbourne, 32 Gisbourne Street, East Melbourne, VIC, 3002, Australia
2 shared publications- Mark Daniell
Centre for Eye Research Australia, University of Melbourne, Melbourne, Victoria, Australia
2 shared publications Alanna Wood
Department of Ophthalmology, Sydney Eye Hospital, Sydney, New South Wales, Australia
1 shared publication
Latest Publications
- Open Access
- 1 January 2026
- Published by Wolters Kluwer Health in Journal of Cataract & Refractive Surgery Online Case Reports
- Vol. 14
Subretinal migration of intraocular and crystalline lens material: report of 2 cases
Introduction: Subretinal lens material is a rare condition with only 10 reported cases: 2 after blunt trauma and 8 after various surgical procedures including phacoemulsification and pars plana lensectomy. This article reviews the current literature and reports 2 unusual cases of subretinal migration of lens material. Patients and Clinical Findings: To the authors' knowledge, case 1 is the second reported case of a subretinal intraocular lens (IOL) and the first to describe its removal. This occurred in a 27-year-old man after femtosecond laser-assisted cataract surgery in the setting of a dislocated IOL and a giant retinal tear. Case 2 describes subretinal migration of a cataractous lens nucleus in a 74-year-old man after phacoemulsification complicated by posterior capsular tear and a giant retinal tear. Diagnosis, Intervention, and Outcomes: In both cases, the subretinal lens material was removed by pars plana vitrectomy using intraocular forceps to maneuver the material through the giant retinal tear. Conclusions: This case report reviews the current literature and highlights the risk of attempting to retrieve a posteriorly dislocated nucleus from an anterior approach, the importance of a thorough preoperative dilated fundus examination, and the potential role of conservative management in selected cases.
- 1 January 2026
- Published by Wolters Kluwer Health in Journal of Cataract & Refractive Surgery Online Case Reports
- Vol. 14
Open AccessSubretinal migration of intraocular and crystalline lens material: report of 2 cases
Introduction: Subretinal lens material is a rare condition with only 10 reported cases: 2 after blunt trauma and 8 after various surgical procedures including phacoemulsification and pars plana lensectomy. This article reviews the current literature and reports 2 unusual cases of subretinal migration of lens material. Patients and Clinical Findings: To the authors' knowledge, case 1 is the second reported case of a subretinal intraocular lens (IOL) and the first to describe its removal. This occurred in a 27-year-old man after femtosecond laser-assisted cataract surgery in the setting of a dislocated IOL and a giant retinal tear. Case 2 describes subretinal migration of a cataractous lens nucleus in a 74-year-old man after phacoemulsification complicated by posterior capsular tear and a giant retinal tear. Diagnosis, Intervention, and Outcomes: In both cases, the subretinal lens material was removed by pars plana vitrectomy using intraocular forceps to maneuver the material through the giant retinal tear. Conclusions: This case report reviews the current literature and highlights the risk of attempting to retrieve a posteriorly dislocated nucleus from an anterior approach, the importance of a thorough preoperative dilated fundus examination, and the potential role of conservative management in selected cases.
- Open Access
- 11 January 2024
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 19 (1) , e0297268
Patterns in refractive error and treatment delay in keratoconus–An Australian study
Keratoconus is the most common primary corneal ectasia and is associated with significant morbidity. In its early stages, keratoconus is often asymptomatic, making the identification of subclinical disease challenging. Refractive error is a parameter that is documented at most routine optometry visits, yet interestingly, changes in refraction of keratoconic patients over time have not yet been studied and compared with the general population. Early diagnosis of keratoconus facilitates timely referral for treatments such as corneal collagen cross-linking, which has been shown to slow disease progression. In this context, documenting delays between initial presentation to the optometrist and referral for collagen-cross-linking as well as comparing the trends in visual acuity and refractive error between keratoconic and non-keratoconic patients over time are particularly relevant.
- 11 January 2024
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 19 (1) , e0297268
Open AccessPatterns in refractive error and treatment delay in keratoconus–An Australian study
Keratoconus is the most common primary corneal ectasia and is associated with significant morbidity. In its early stages, keratoconus is often asymptomatic, making the identification of subclinical disease challenging. Refractive error is a parameter that is documented at most routine optometry visits, yet interestingly, changes in refraction of keratoconic patients over time have not yet been studied and compared with the general population. Early diagnosis of keratoconus facilitates timely referral for treatments such as corneal collagen cross-linking, which has been shown to slow disease progression. In this context, documenting delays between initial presentation to the optometrist and referral for collagen-cross-linking as well as comparing the trends in visual acuity and refractive error between keratoconic and non-keratoconic patients over time are particularly relevant.
- Open Access
- 30 April 2019
- Published by Wiley in Case Reports in Ophthalmological Medicine
- Vol. 2019, 1-5
An Unusual Presentation of Pediatric Conjunctival Mucosa-Associated Lymphoid Tissue Lymphoma
Ocular adnexal mucosa-associated lymphoid tissue (MALT) lymphoma is uncommon in the pediatric population. Initial misdiagnosis is common and there is lacking consensus regarding the optimal approach to treatment. Herein, we report an atypical presentation of pediatric conjunctival MALT lymphoma and review the presentation and management of this rare condition.
- 30 April 2019
- Published by Wiley in Case Reports in Ophthalmological Medicine
- Vol. 2019, 1-5
Open AccessAn Unusual Presentation of Pediatric Conjunctival Mucosa-Associated Lymphoid Tissue Lymphoma
Ocular adnexal mucosa-associated lymphoid tissue (MALT) lymphoma is uncommon in the pediatric population. Initial misdiagnosis is common and there is lacking consensus regarding the optimal approach to treatment. Herein, we report an atypical presentation of pediatric conjunctival MALT lymphoma and review the presentation and management of this rare condition.
- 19 February 2019
- Published by Springer Nature in Eye
- Vol. 33 (7) , 1186-1187
Management of the photic sneeze reflex utilising the philtral pressure technique
- 19 February 2019
- Published by Springer Nature in Eye
- Vol. 33 (7) , 1186-1187
Management of the photic sneeze reflex utilising the philtral pressure technique
- 1 January 2019
- Published by CSIRO Publishing in Australian Journal of Primary Health
- Vol. 25 (5) , 402-405
Ethics of medical research in Aboriginal and Torres Strait Islander populations
Conducting ethical health research in Aboriginal and Torres Strait Islander populations requires an understanding of their unique cultural values and the historical context. The assimilation of Indigenous people with the broader community through colonial policies such as the dispossession of land and forcible removal of children from their families in the Stolen Generation, deprived entire communities of their liberty. Poorly designed research protocols can perpetuate discriminatory values, reinforce negative stereotypes and stigmas and lead to further mistrust between the Indigenous community and healthcare professionals. The manuscript offers a fresh perspective and an up-to-date literature review on the ethical implications of conducting health research in Aboriginal and Torres Strait Islander communities.
- 1 January 2019
- Published by CSIRO Publishing in Australian Journal of Primary Health
- Vol. 25 (5) , 402-405
Ethics of medical research in Aboriginal and Torres Strait Islander populations
Conducting ethical health research in Aboriginal and Torres Strait Islander populations requires an understanding of their unique cultural values and the historical context. The assimilation of Indigenous people with the broader community through colonial policies such as the dispossession of land and forcible removal of children from their families in the Stolen Generation, deprived entire communities of their liberty. Poorly designed research protocols can perpetuate discriminatory values, reinforce negative stereotypes and stigmas and lead to further mistrust between the Indigenous community and healthcare professionals. The manuscript offers a fresh perspective and an up-to-date literature review on the ethical implications of conducting health research in Aboriginal and Torres Strait Islander communities.
- 1 January 2019
- Published by CSIRO Publishing in Australian Journal of Primary Health
- Vol. 25 (5) , 387-388
The central concept of empowerment in Indigenous health and wellbeing
The Australian Journal of Primary Health is published by CSIRO PUBLISHING on behalf of the Australian Institute for Primary Care and School of Public Health, La Trobe University in association with the Primary and Community Health Network. The Journal is a refereed, international journal designed to publish articles on a range of issues influencing community health services and primary health care. The focus of the Australian Journal of Primary Health is on the integration of theory and practice in primary health utilising perspectives from a range of disciplines. The Journal publishes research articles, policy reports and analyses, book reviews, case reports, the views of practitioners, consumers, carers, students, and special interest groups, and descriptions of professional practice initiatives in the field of primary health care
- 1 January 2019
- Published by CSIRO Publishing in Australian Journal of Primary Health
- Vol. 25 (5) , 387-388
The central concept of empowerment in Indigenous health and wellbeing
The Australian Journal of Primary Health is published by CSIRO PUBLISHING on behalf of the Australian Institute for Primary Care and School of Public Health, La Trobe University in association with the Primary and Community Health Network. The Journal is a refereed, international journal designed to publish articles on a range of issues influencing community health services and primary health care. The focus of the Australian Journal of Primary Health is on the integration of theory and practice in primary health utilising perspectives from a range of disciplines. The Journal publishes research articles, policy reports and analyses, book reviews, case reports, the views of practitioners, consumers, carers, students, and special interest groups, and descriptions of professional practice initiatives in the field of primary health care
- 1 December 2018
- Published by Elsevier in Experimental Eye Research
- Vol. 177, 65-75
The current state of stem cell therapy for ocular disease
- 1 December 2018
- Published by Elsevier in Experimental Eye Research
- Vol. 177, 65-75
The current state of stem cell therapy for ocular disease
- Open Access
- 19 June 2018
- Published by Springer Nature in Eye
- Vol. 32 (10) , 1636-1643
Incidence, clinical features and diagnosis of cicatrising conjunctivitis in Australia and New Zealand
This study aimed to determine the incidence, clinical features and management of cicatrising conjunctivitis in Australia and New Zealand, also enabling comparison with data from the United Kingdom. A prospective surveillance study was conducted over 17 months via the Australian and New Zealand Ophthalmic Surveillance Unit with a one-year follow-up period. Practicing ophthalmologists on the Surveillance Unit’s database were asked to report recently diagnosed cases of cicatrising conjunctivitis on a monthly basis. Initial and follow-up questionnaires were sent to ophthalmologists who had reported positive cases to obtain demographic and clinical data. The minimum incidence of cicatrising conjunctivitis was calculated based on cases reported during the study period and from population data. During the 17-month study period (December 2011–April 2013), 56 cases of cicatrising conjunctivitis were reported. Data was obtained for 35 cases (62%) with a mean age of 74 years (range, 28–94 years). The most common aetiologies were ocular mucus membrane pemphigoid (n = 18 cases, 51.4%), Stevens–Johnson Syndrome (n = 3, 8.6%) and graft versus host disease (n = 3, 8.6%). The minimum incidence of cicatrising conjunctivitis in Australia and New Zealand was 1.5 per million, comparable to incidence data from the United Kingdom. This study is the first to prospectively record the incidence of cicatrising conjunctivitis in Australia and New Zealand and the second worldwide. It provides novel data on demographics and management of cicatrising conjunctivitis, as reported by treating ophthalmologists.
- 19 June 2018
- Published by Springer Nature in Eye
- Vol. 32 (10) , 1636-1643
Open AccessIncidence, clinical features and diagnosis of cicatrising conjunctivitis in Australia and New Zealand
This study aimed to determine the incidence, clinical features and management of cicatrising conjunctivitis in Australia and New Zealand, also enabling comparison with data from the United Kingdom. A prospective surveillance study was conducted over 17 months via the Australian and New Zealand Ophthalmic Surveillance Unit with a one-year follow-up period. Practicing ophthalmologists on the Surveillance Unit’s database were asked to report recently diagnosed cases of cicatrising conjunctivitis on a monthly basis. Initial and follow-up questionnaires were sent to ophthalmologists who had reported positive cases to obtain demographic and clinical data. The minimum incidence of cicatrising conjunctivitis was calculated based on cases reported during the study period and from population data. During the 17-month study period (December 2011–April 2013), 56 cases of cicatrising conjunctivitis were reported. Data was obtained for 35 cases (62%) with a mean age of 74 years (range, 28–94 years). The most common aetiologies were ocular mucus membrane pemphigoid (n = 18 cases, 51.4%), Stevens–Johnson Syndrome (n = 3, 8.6%) and graft versus host disease (n = 3, 8.6%). The minimum incidence of cicatrising conjunctivitis in Australia and New Zealand was 1.5 per million, comparable to incidence data from the United Kingdom. This study is the first to prospectively record the incidence of cicatrising conjunctivitis in Australia and New Zealand and the second worldwide. It provides novel data on demographics and management of cicatrising conjunctivitis, as reported by treating ophthalmologists.
- 4 June 2018
- Published by SAGE Publications in Cephalalgia
- Vol. 39 (2) , 316-322
Isolated painful trigeminal neuropathy as an unusual presentation of chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids: A case report
Background: Chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids (CLIPPERS) is an inflammatory central nervous system disorder, typically presenting with subacute symptoms referable to brainstem and cerebellar pathology. This is the first report of CLIPPERS presenting with a painful trigeminal neuropathy. Case report: We report an unusual case of CLIPPERS presenting with facial pain and sensory symptoms, in the absence of other brainstem or cerebellar signs. Perivascular enhancement of peri-pontine structures on neuroimaging, lymphocytic infiltrate on histopathology and rapid clinical and radiological responsiveness to glucocorticosteroids were key to diagnosis. Extensive investigations excluded various differential aetiologies. Conclusion: The pathogenesis of CLIPPERS is poorly understood, and the diagnostic criteria are yet to be validated. In this case, facial pain was not associated with other brainstem or cerebellar signs, broadening current understanding of how CLIPPERS may present. This has clinical implications in guiding future investigations for patients presenting with painful trigeminal neuropathy.
- 4 June 2018
- Published by SAGE Publications in Cephalalgia
- Vol. 39 (2) , 316-322
Isolated painful trigeminal neuropathy as an unusual presentation of chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids: A case report
Background: Chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids (CLIPPERS) is an inflammatory central nervous system disorder, typically presenting with subacute symptoms referable to brainstem and cerebellar pathology. This is the first report of CLIPPERS presenting with a painful trigeminal neuropathy. Case report: We report an unusual case of CLIPPERS presenting with facial pain and sensory symptoms, in the absence of other brainstem or cerebellar signs. Perivascular enhancement of peri-pontine structures on neuroimaging, lymphocytic infiltrate on histopathology and rapid clinical and radiological responsiveness to glucocorticosteroids were key to diagnosis. Extensive investigations excluded various differential aetiologies. Conclusion: The pathogenesis of CLIPPERS is poorly understood, and the diagnostic criteria are yet to be validated. In this case, facial pain was not associated with other brainstem or cerebellar signs, broadening current understanding of how CLIPPERS may present. This has clinical implications in guiding future investigations for patients presenting with painful trigeminal neuropathy.
- 1 September 2016
- Published by Wiley in Clinical & Experimental Ophthalmology
- Vol. 45 (2) , 174-181
Nature and incidence of severe limbal stem cell deficiency in Australia and New Zealand
Background: This study aimed to determine the nature and incidence of severe limbal stem cell deficiency (LSCD) in Australia and New Zealand.Design: A 1‐year pilot surveillance study with a 1‐year follow‐up period was conducted in association with the Australian and New Zealand Ophthalmic Surveillance Unit.Participants: The study included patients reported by practising ophthalmologists on the Surveillance Unit's database.Methods: Ophthalmologists were provided with a definition of severe limbal stem cell deficiency, contacted on a monthly basis by the Unit and asked to report newly diagnosed cases.Main Outcome Measures: Severe LSCD was defined as at least 6 clock hours of whorl‐like epitheliopathy, an opaque epithelium arising from the limbus, late fluorescein staining of the involved epithelium and superficial corneal neovascularization or conjunctivalization.Results: On average, 286 report cards were sent by the Surveillance Unit to practising ophthalmologists each month (total 3429 over 12 months) and the Unit received an average of 176 responses per month (total 2111; 62% response rate). During the 1‐year study period from April 2013 to March 2014, 14 positive cases were reported to the Unit. A range of underlying aetiologies were implicated, with contact lens over‐wear and cicatrizing conjunctivitis being the most common (n = 3).Conclusions: This surveillance study is the first worldwide to document the incidence of limbal stem cell deficiency; however, because of study design limitations, it is likely to have been under‐reported. It provides novel data on the demographics, clinical conditions and management of patients with limbal stem cell deficiency as reported by treating ophthalmologists.
- 1 September 2016
- Published by Wiley in Clinical & Experimental Ophthalmology
- Vol. 45 (2) , 174-181
Nature and incidence of severe limbal stem cell deficiency in Australia and New Zealand
Background: This study aimed to determine the nature and incidence of severe limbal stem cell deficiency (LSCD) in Australia and New Zealand.Design: A 1‐year pilot surveillance study with a 1‐year follow‐up period was conducted in association with the Australian and New Zealand Ophthalmic Surveillance Unit.Participants: The study included patients reported by practising ophthalmologists on the Surveillance Unit's database.Methods: Ophthalmologists were provided with a definition of severe limbal stem cell deficiency, contacted on a monthly basis by the Unit and asked to report newly diagnosed cases.Main Outcome Measures: Severe LSCD was defined as at least 6 clock hours of whorl‐like epitheliopathy, an opaque epithelium arising from the limbus, late fluorescein staining of the involved epithelium and superficial corneal neovascularization or conjunctivalization.Results: On average, 286 report cards were sent by the Surveillance Unit to practising ophthalmologists each month (total 3429 over 12 months) and the Unit received an average of 176 responses per month (total 2111; 62% response rate). During the 1‐year study period from April 2013 to March 2014, 14 positive cases were reported to the Unit. A range of underlying aetiologies were implicated, with contact lens over‐wear and cicatrizing conjunctivitis being the most common (n = 3).Conclusions: This surveillance study is the first worldwide to document the incidence of limbal stem cell deficiency; however, because of study design limitations, it is likely to have been under‐reported. It provides novel data on the demographics, clinical conditions and management of patients with limbal stem cell deficiency as reported by treating ophthalmologists.